The discovery that Gal-3 expression has a negative correlation with ITGB3 and LYN expression and a positive correlation with p-CTNNB1 expression in AML-derived MSCs, implies that these proteins may be part of a pathway that mediates MSC-induced drug resistance of AML cells. The gene discussed is LGALS3; the disease is acute myeloid leukemia.